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What’s already known about this topic?  
 Diagnostic criteria can aid both clinical diagnosis and support standardisation in 
clinical trials and observational research. 
 In routine dermatology practice, psoriasis is a clinical diagnosis and the gold 
(reference) standard is a dermatologist’s diagnosis, supported where needed by 
histology.  
 Diagnostic criteria are currently not widely used in clinical practice or research on 
psoriasis. 
 
What does this study add?  
 No clinical examination-based diagnostic criteria have been developed or validated 
for psoriasis in adults or children  
 Genetic, molecular, skin imaging, histopathology, questionnaire-based, computer-
aided and traditional Chinese medicine diagnostic criteria have been developed for 
psoriasis, but their utility in clinical practice and research needs further exploration.  
 Many of the included diagnostic accuracy studies had unclear or high risk of bias due 
to weaknesses in study design and study reporting. 
Abstract 
 
Background 
The diagnosis of psoriasis in adults and children is made clinically, for both patient 
management and the selection of participants in research. Diagnostic criteria provide a 
structure for clinical assessment, which in turn helps standardise patient recruitment into 
clinical trials and case definitions in observational studies. 
 
Objective 
The aim of this systematic review was to identify and critically appraise the published 
studies to date that had a primary research aim to develop or validate diagnostic criteria for 
psoriasis. 
 
Method 
A search of Ovid MEDLINE and Ovid Embase was conducted in October 2016. The primary 
objective was sensitivity and specificity of diagnostic criteria for psoriasis. Secondary 
objectives included diagnostic recommendations, applicability to children and study 
characteristics. Diagnostic accuracy studies were critically appraised for risk of bias using the 
QUADAS-2 tool. 
 
Results 
Twenty-three studies met the inclusion criteria.None detailed clinical examination-based 
diagnostic criteria. The included criteria varied from genetic and molecular diagnostic 
models to skin imaging, histopathology, questionnaire-based, computer-aided and 
traditional Chinese medicine criteria. High sensitivity and specificity (>90%) were reported in 
many studies. However, the study authors often did not specify how criteria would be used 
clinically or in research. This review identified studies with varyingrisk of bias and due to 
each study developing separate criteria meta-analysis was not possible.  
 
Conclusion 
Clinical examination-based diagnostic criteria are currently lacking for psoriasis. Future 
research could follow an international collaborative approach and employ high quality 
diagnostic accuracy study design. Existing and newly developed criteria require validation.  
Introduction 
 
The aim of this systematic review was to identify and critically appraise studies where the 
primary research aim was to develop or validate diagnostic criteria for psoriasis in adults or 
children. The review was designed to be broad and inclusive of all ages, types of psoriasis 
and types of diagnostic criteria. In this way, the review aimed to provide a comprehensive 
overview of the available evidence. 
 
Psoriasis is an immune-mediated chronic inflammatory disease affecting the skin, joints, or 
both. It is associated with both a genetic predisposition and environmental triggers1. Onset 
may occur at any age, with an estimated prevalence of 1.0% to 8.5% in adults and up to 
2.1% in children2,3. Psoriasis is associated with systemicinflammation , although the risk of 
comorbidity and comorbidity-related mortality remains controversial4-7. 
 
In routine clinical practice, the diagnosis of psoriasis is made based on pattern recognition of 
clinical features, including the distribution, configuration and morphology of skin changes8-
10. The gold or reference standard is conventionally accepted to be a clinical diagnosis made 
by a qualified dermatologist, which may be supported, when required, by a skin biopsy. 
Unlike in other conditions such as Behçets disease, where clinical diagnostic criteria exist to 
aid the clinical assessment, and atopic dermatitis, where criteria are used in clinical 
research, diagnostic criteria are not widely used in the assessment of psoriasis11-13.  
 
Clinical diagnostic criteria not only support and provide a structure to clinical diagnosis, but 
also standardise recruitment into clinical trials and case definitions in observational studies. 
Studies which develop diagnostic criteria should follow the principles of high quality 
diagnostic accuracy study design and reporting, and then go on to validate the criteria in the 
study or clinical population they are intended to be used14.  
Method 
 
The protocol was registered on PROSPERO 
(http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015032311), and the 
results have been reported according to the PRISMA checklist15. The term ‘diagnostic 
criteria’ was interpreted to mean a group of diagnostic features which support a diagnosis 
of psoriasis. 
 
Studies were included where the primary aim was to develop or validate diagnostic criteria 
for psoriasis. No restrictions were applied to study type, age of participants, language, type 
of psoriasis or type of diagnostic criteria developed. Studies were not required to include a 
comparator group. . Review articles and studies focusing solely on psoriatic arthritis were 
excluded. Conference abstracts were excluded due to insufficient information; this was an 
alteration from the protocol.  
 
The primary outcome was sensitivity and specificity of diagnostic criteria for psoriasis. 
Secondary outcomes were as follows: recommendations on how to diagnose psoriasis, 
applicability of the diagnostic criteria to a paediatric population, study design and study 
population. The diagnosis of psoriasis can be more challenging in children, in part due to a 
different presentation compared to adults, therefore this review assessed the applicability 
of diagnostic criteria to this specific population.  
 
The search was conducted in October 2016 in Ovid MEDLINE(R) In-Process & Other Non-
Indexed Citations, Ovid MEDLINE(R) 1946 to Present, and Ovid Embase 1974 to 2015. A 
search strategy was developed with an information specialist (DG) using MeSH headings and 
free text search terms around the keywords ‘diagnosis’, ‘criteria’ and ‘psoriasis’ (Appendix 
1). Reference citations from included studies were searched for additional relevant papers. 
 
Titles and abstracts of identified studies were independently screened by two authors 
according to the inclusion and exclusion criteria (EBT and either RP, SR or DG). Full text 
papers were obtained for studies meeting the inclusion criteria. Two authors (EBT and RP) 
independently assessed the eligibility of full text papers. Study authors were contacted to 
clarify missing data from potentially eligible studies. Any disagreements on study eligibility 
were resolved through discussion or involvement of a third author (KT).  
 
Data were independently extracted by two authors (EBT and RP) using a standardised 
proforma (Appendix 2). The proforma was piloted on three studies and refined before 
independent extraction was initiated. Discrepancies between the two sets of data extraction 
were discussed and checked against the original manuscript. For those studies not reported 
in English, data was extracted by an associate proficient in that language.  
 
Diagnostic accuracy studies were individually critically appraised for risk of bias using the 
QUADAS-216. The QUADAS-2 tool was specifically designed to assess the quality of studies 
included in diagnostic accuracy systematic reviews. The tool assesses risk of bias across four 
domains; each guided by prompt questions. Patient selection: recruitment of consecutive or 
a random sample, case-control design avoided, inappropriate exclusions.  Index test 
(diagnostic criteria): results interpreted without knowledge of the reference standard, use 
of a pre-specified threshold. Reference standard (gold standard): results interpreted without 
knowledge of the index test, likely to correctly classify psoriasis.  Flow of patients in the 
study: interval between index test and reference standard, complete verification, inclusion 
of all patients in the analysis. All studies, regardless of overall quality, were included in data 
synthesis. 
 
Paired forest plots and summary ROC (SROC) curves were planned for studies which were 
clinically similar and suitable for meta-analysis. A narrative synthesis was planned for 
secondary outcomes.      
Results 
 
Within the 11,702 studies identified from the search strategy no clinical examination based 
diagnostic criteria for psoriasis in adults or children were found. Only 23 studies17-39 met the 
inclusion criteria and presented a broad range of diagnostic criteria including genetic, 
molecular, dermoscopy, confocal microscopy, histopathology, questionnaire-based, 
computer aided and traditional Chinese medicine criteria (Table 1). Sixteen 22studies were of 
a case-control design, five studies were case-series, one study was cross-sectional and one 
study was a Delphi consensus study. No studies developed diagnostic criteria specifically for 
children or validated diagnostic criteria specifically in a paediatric population. 
 
Studies were excluded because they were duplicates (n=4374), did not focus on psoriasis 
(n=4266), did not mention diagnostic criteria for psoriasis (n=2950), did not develop or 
validate diagnostic criteria (n=34) or were review articles (n=55). The search strategy was 
extensive and inclusive of many terms associated with diagnostic criteria and psoriasis. A 
large number of studies were therefore excluded at the screening stage. A PRISMA flow 
diagram of included and excluded studies is presented in Figure 1.  
 
The diagnostic criteria have been summarised, including consideration of their utility, and 
study quality is reported using the QUADAS-2 tool. With regards to the review primary 
outcome, sensitivity and specificity of the diagnostic criteria, only 16 of the included studies 
were diagnostic accuracy studies 17-20,22-24,26-29,31,35-38 and of these studies only thirteen  
studies provided these data18,20,22-24,26-29,31,35,36,38. Figure 2 shows a scatterplot of the 
available sensitivity and specificity results of these 13 studies.  
 
Meta-analysis was not appropriate due to heterogeneity of the diagnostic criteria in terms 
of different study populations, experimental and reference tests 40, therefore a narrative 
review was undertaken. 
 
Genetic and moleculardiagnostic criteria 
Six studies reported genetic18-21,23,24 and three studies reported molecular17,22 diagnostic 
criteria (Table 1). These studies aimed to identify a combination of genetic or molecular 
markers which could best predict psoriasis. Seven studies were of a case-control design and 
one was a cross-sectional study. Sensitivity and specificity results of the criteria were 
presented or available on request for five studies; the sensitivity values ranged from 65.6 to 
98 and specificity from 58.2 to 10018,20,22-24. Diagnostic accuracy results were oftenreported 
as area under the curve (AUC) and three studies reported a value of 0.7 or greater17,18,22,24. 
Six studies undertook validation testing of their developed criteria17,19-21,23,24; in two 
studies20,24 this was conducted in a separate cohort but no studies reported validation in 
their intended population.  
 
Domain 1 (patient selection) was scored high risk of bias in six studies 17-19,22-24, the 
remaining three domains nearly all scored low or unclear risk of bias in the seven diagnostic 
accuracy studies (Figure 3). The low scores reflect that the index test was interpreted 
separately from the reference standard and the flow of patients through each study 
minimised bias. However, the reference standard was only detailed in one study24. 
 
Across the eight studies, the study authors proposed that their research may improve the 
efficiency and/or accuracy of diagnosis including screening individuals at high risk for 
psoriasis19,24, improve disease outcomes17, further understanding of pathogenesis18,20 and 
aid the development of personalised medicine20,24 and new treatment23. The authors of two 
studies proposed that these genetic criteria would, in time, translate into routine clinical 
practice20,23.  
 
We conclude that the research and clinical utility of these genetic and molecular criteria for 
the diagnosis of psoriasis require further exploration, and new validation studies are 
needed. The cost of the laboratory investigation and skill required to undertake a skin 
biopsy for current genetic testing are likely to be barriers to adoption. The effect of the 
anatomical distribution of psoriasis on the predictive ability of these criteria is unknown.  
 
Skin imaging diagnostic criteria 
Four studies reported dermoscopic or videodermoscopic diagnostic criteria27-30, two studies 
reported reflective confocal microscopy (RCM)26,31 criteria and one study reported high 
definition optical confocal tomography (HD-OCT)25 (Table 1). All seven studies were of a 
case-control study design and five studies26-29,31 assessed the diagnostic accuracy of the 
proposed criteria in distinguishing psoriasis from other inflammatory skin disease and skin 
cancer. 
 
The different dermoscopic criteria studies reported variable sensitivity (45% to 98%), but 
high specificity (88% to 99.5%) for diagnosing psoriasis27-29. Koller et al26reported high 
sensitivity (89.13%) and specificity (95.41%) for the RCT criteria tested and Munro’s 
microabscesses on RCT achieved both high sensitivity and specificity (90% and 96.4%)31. The 
Videodermoscopy Scalp Psoriasis Severity Index (VSCAPSI) criteria had poor inter-observer 
reproducibility; only 68% of dermatologists recognised ≥13 images30. None of the imaging 
studies included testing the diagnostic criteria in a validation cohort.  
 
The risk of bias was highly variable across the five diagnostic accuracy studies (Figure 3). 
These scores not only reflect study quality but also the quality of study reporting; for 
example the details reported by Liu et al28 and Zhong et al31 were brief and therefore many 
of the domains were scored as unclear. Lallas et al and Koller et al26,27 achieved a low risk of 
bias score in three out of four domains, demonstrating both a strong study design and 
detailed reporting.  
 
The authors of the seven skin imaging studies proposed that the developed criteria may 
assist clinical diagnosis reducing the need for skin biopsy25,29,31, help identify an optimal site 
to biopsy 26, enable response to treatment and side effect monitoring27, and help identify 
patients requiring screening for psoriatic arthritis30.  One group of authors highlighted that 
the feasibility of applying imaging criteria in clinical practice requires further evaluation27. 
The authors of one study suggested that the criteria could be adopted as an outcome tool in 
clinical trials30.  
 
We conclude that further discussion about the clinical and research utility of imaging criteria 
in the diagnosis of psoriasis is needed, including validation of their diagnostic accuracy in the 
proposed setting and population. The implementation of imaging criteria research is likely 
to be restricted to the specialist setting due to the availability of equipment and trained 
professionals. Dermoscopy is already widely practised amongst dermatologists for the 
assessment of skin cancer and therefore further training could extend existing skills to 
inflammatory lesions. However, the availability of confocal microscopy is limited to 
specialist research centres. Further studies are also needed to guide lesion selection, as it is 
not clear whether the performance of the criteria varies when plaques at different 
anatomical sites are assessed. 
 
Histopathological diagnostic criteria 
Four studies have contributed to the development of histopathological criteria32-35, focusing 
on clinical situations where diagnosing psoriasis is recognised as challenging; isolated scalp 
psoriasis, isolated nail psoriasis, erythroderma (Table 1). Three studies were case-series and 
one35 was of a case-control design and provided diagnostic accuracy data. None included a 
validation cohort. Park et al35 reported poor sensitivity (33%) and good specificity (90%) of 
>5.75 mitotic features in one high power field for the diagnosis of psoriasis. Minimal study 
details were provided and therefore the risk of bias was high or unclear across the four 
domains evaluated (Figure 3). The study was strengthened by assessment of histological 
samples by three independent histopathologists, but no intra-observer data was provided. 
 
The authors of the four histopathology studies provided few details on the potential 
application of the proposed diagnostic criteria, except stating they would assist clinical 
diagnosis. We conclude that the clinical and research utility of histopathological criteria is 
poorly explored, especially considering histology was often part of the inclusion criteria for 
many studies within this review. A skin biopsy is a small but invasive procedure, incurs costs 
and is not widely available outside the specialist setting. These factors are likely to limit the 
adoption of histological criteria outside dermatology clinics and within clinical trials. 
Clinically, histological criteria may be of greatest benefit in those with indeterminate skin 
changes. The criteria proposed are for specific anatomical sites, and therefore it is unknown 
if these findings are applicable to other body sites.  
 
Computer-aided diagnostic criteria 
Two case-control studies developed computer-aided diagnostic criteria and reported high 
diagnostic accuracy (sensitivity and specificity 100%, 5.7 errors per 100 cases)36 (Table 1). 
Neither included a validation group. The risk of bias across the four domains varied between 
the two studies, reflecting the specific details reported in West and West on the reference 
test and index test36,37 (Figure 3).  
 
Both sets of authors proposed that their criteria would be used in the clinical setting, 
although differed on whether the computer-aided tool would augment or replace current 
diagnostics. We propose that further discussion of clinical and research utility is needed, 
and validation studies. The performance of the criteria when psoriasis affects specific body 
areas is unknown.  
 
Questionnaire-based diagnostic criteria 
Dominguez et al  developed a self-administered screening questionnaire for the diagnosis of 
psoriasis38.  In this case-control study the questionnaire achieved high diagnostic accuracy; 
sensitivity 98% and specificity 95%38. However, the performance of the questionnaire relied 
heavily on question number three, ‘I have been diagnosed with psoriasis by a dermatologist’ 
(sensitivity 93%, specificity 98%), and removal of this question led the sensitivity and 
specificity to fall to 35% and 50% respectively38.  
 
The risk of bias assessment was variable across the four domains. In particular, the quality of 
the study was limited by lack of clarity as to whether the index test (questionnaire) was 
separated from the reference standard (dermatologist’s diagnosis) (Figure 3).  
 
The study authors designed the questionnaire for research purposes and aimed to reliably 
ascertain psoriasis and psoriasis subtypes in remote populations38. We conclude that the 
diagnostic accuracy of the criteria may be poor in areas with low levels of access to 
dermatologists, potentially limiting its usefulness in this setting. Future studies are needed 
to validate the questionnaire in a community setting. A questionnaire is a low-cost 
diagnostic tool, making it suitable for large and population-based studies. It is not clear what 
impact limited psoriasis or psoriasis affecting only certain body sites may have on the 
questionnaire’s diagnostic ability.  
 
Traditional Chinese Medicine diagnostic criteria 
A Delphi consensus study, Yang et al 39 aimed to develop a checklist for traditional Chinese 
medicine symptoms and signs of psoriasis. The study did not assess diagnostic accuracy, 
but within the consensus study there was good intra-observer but poor inter-observer 
agreement. 
 
The study authors proposed that the criteria may aid the diagnosis and classification of 
psoriasis in clinical practice and research39, but no further details were provided. We 
conclude that further discussion about the criteria’s utility is needed and testing of its 
diagnostic performance. No reference was made to psoriasis affecting specific body areas. It 
is likely that the usefulness of these criteria will be mostly limited to settings practising 
traditional Chinese medicine.  
 
Discussion 
Summary of key findings 
This systematic review identified 23 studies that reported diagnostic criteria for psoriasis, 
but it is surprising that no clinical examination-based diagnostic criteria have been 
developed or tested. The questionnaire-based criteria by Dominguez et al 38 were the 
closest in type to clinical diagnostic criteria, but relied on patient confirmation of a 
dermatologist’s diagnosis. Validation was frequently performed within studies developing 
genetic and molecular criteria, but no studies validated their criteria in the setting and 
population they were intended to be used.   Due to the heterogeneity of diagnostic criteria 
included in this review it was not possible to compare their diagnostic accuracy. 
Nevertheless, high sensitivity and specificity (>90%) were reported in many studies.  
 
The majority of included studies were limited by their case-control design, which is likely to 
over-estimate the diagnostic accuracy of a test or tool41,42. There was also significant 
variation in study reporting, with frequent or high risk of bias in domains where details were 
limited or missing about the study population, reference standard and flow of patients in 
the study16. Nearly all diagnostic accuracy studies were undertaken on a selected population 
using a case-control study design and therefore the QUADAS-2 domain 1 (patient selection) 
was rated high risk of bias in all critically appraised studies. 
 
Overall, studies often poorly described the clinical and research utility of their proposed 
criteria, or future research required to validate and implement them. Studies focused, 
where detailed, on plaque psoriasis and the diagnostic performance of the criteria across a 
variety of body areas is unknown.  
 
Diagnostic criteria in dermatology  
The benefits of diagnostic criteria in supporting improved clinical diagnosis, research studies 
and systematic reviews are widely reported9,43,44. However, diagnostic criteria have only 
been developed for a small number of diseases in dermatology;  
 
In eczema, Brenninkmeijer et al 12 summarised and assessed the validity of six examination-
based diagnostic criteria, developed mostly for research purposes. These criteria achieved 
varied diagnostic accuracy and Brenninkmeijer et al commented that the methodological 
quality in both the conduct and reporting of the eczema studies differed substantially; a 
similar finding to this review on diagnostic criteria for psoriasis. In Behçet’s disease, Davatchi 
et al 45 appraised 17 sets of examination-based diagnostic criteria that were developed to 
aid clinical diagnosis. Two internationally developed sets of diagnostic criteria for Beçhet’s 
disease were found to be the best performing criteria. The review emphasised that further 
validation studies in different countries were required and the need to accept that the 
clinical picture of a disease may change over time45. These are both concepts which need to 
be considered when developing diagnostic criteria for psoriasis.  
 
Diagnostic criteria have also been proposed for a small number of other dermatological 
conditions, primarily those with extra-cutaneous involvement and those requiring multi-
professional input. For example, mucous membrane pemphigoid, PHACE (Posterior fossa, 
Haemangioma, Arterial lesions, Cardiac abnormalities, Eye abnormalities) syndrome and 
erosive lichen planus46-48   
 
Relevance to clinical practice 
Diagnostic criteria in dermatology aim to support not replace clinical diagnosis, especially in 
the specialist setting where the reference standard is a dermatologist’s diagnosis. In this 
review many of the criteria identified were ‘test-based’. The utility of skin imaging or 
histopathological diagnostic criteria alone may be limited, as they are unlikely to be used 
without a clinical assessment. However, they are likely to be useful adjuvants to clinical 
diagnosis for example, in cases of clinical diagnostic uncertainty where a dermoscopic 
followed by a histopathological diagnostic criteria may be applied. At present, it is more 
difficult to recognise how genetic or molecular diagnostic criteria would be used in routine 
clinical practice.  
 
Most studies in this review, where stated, included an adult secondary care population, 
therefore the findings of this review would be difficult to translate to children or a 
community setting where the diagnostic challenges are different.  
 
The implications for patients of not receiving an accurate psoriasis diagnosis (false 
negatives) include a delay in initiating effective treatment and monitoring for comorbidities. 
Incorrectly identifying patients with psoriasis (false positives) may result in inappropriate 
treatment for their skin condition and the possible anxiety of being labelled with a 
potentially life-long skin condition.  
 
Research implications 
Only the questionnaire-based diagnostic criteria were specifically developed for research 
purposes38. However, the diagnostic accuracy of this tool in the community setting has not 
yet been assessed in a validation study. Genetic and molecular diagnostic criteria may play 
an important role in future geno-epidemiological studies, developing biobanks and 
stratifying patients according to disease. However, further work is needed to improve the 
diagnostic accuracy of such criteria and validate them.  
 
The diagnostic criteria identified in this review are currently not suitable to standardise 
psoriasis disease definition in clinical trials and observational studies; confirming an 
important gap in the available literature.  
Strengths and limitations 
To the authors’ knowledge this review is the first to collate and appraise available studies 
that have developed and/or validated diagnostic criteria for psoriasis. The search strategy 
was designed to be comprehensive and was supported by an information specialist. 
Diagnostic accuracy studies were critically appraised using the validated QUADAS-2 tool. As 
the literature in this area was anticipated to be limited a broad definition of diagnostic 
criteria was applied. Therefore, the types of diagnostic criteria included in this review are 
diverse and meta-analysis was not possible.  
Conclusions 
At present there are no available clinical examination-based diagnostic criteria for psoriasis 
to support clinical diagnosis and standardisation of disease definition in research studies. A 
number of criteria based on different diagnostic methods have been developed but their 
clinical and research utility is unclear. There is a need for these proposed criteria to be 
validated in the populations and settings they are intended to be used. To date, studies have 
focused on the adult population. The work to develop clinical examination-based diagnostic 
criteria chould be undertaken as an international collaborative approach, consider the type 
and extent of psoriasis, aim to minimise the risk of bias in the study design and propose to 
validate the criteria in the target population. Such work should carefully consider the 
diagnostic challenges of psoriasis affecting particular sites and ages.   
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